Cargando…
392 Lung Toxicity Induced by Novel Antineoplastic Therapies in Cancer Patients
BACKGROUND: Pulmonary toxicity and respiratory failure are major adverse events complicating the use of novel antineoplastic agents in the treatment of lung cancer. We aim to investigate the risk and characteristics of cytostatic-induced pulmonary toxicity caused by agents currently used to treat lu...
Autores principales: | Syrigos, Kostas N., Vassos, Dimitrios, Makrilia, Nektaria, Tsimpoukis, Sotirios, Politi, Ekaterini, Dannos, Ioannis, Syrigou, Ekaterini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512795/ http://dx.doi.org/10.1097/01.WOX.0000412155.24489.f9 |
Ejemplares similares
-
255 Chronic Obstructive Pulmonary Disease and Lung Cancer Share Inflammation Pathways
por: Syrigos, Kostas N., et al.
Publicado: (2012) -
322 Preoperative Cardiopulmonary Exercise Testing (CPET) in Severe Asthma Patients
por: Syrigou, Ekaterini, et al.
Publicado: (2012) -
311 Pathogenesis of Radiation-induced Pneumonitis in Patients with Chronic Obstructive Pulmonary Disease
por: Politi, Ekaterini, et al.
Publicado: (2012) -
310 Diagnosis and Management of Post-radiation Pneumonitis in Patients with Asthma
por: Syrigou, Ekaterini, et al.
Publicado: (2012) -
Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review
por: Makrilia, Nektaria, et al.
Publicado: (2010)